- Title
- Correlation analyses of radiographic progression-free survival with clinical and health-related quality of life outcomes in metastatic castration-resistant prostate cancer: Analysis of the phase 3 VISION trial
- Creators
- Michael J. Morris - Memorial Sloan Kettering Cancer CenterJohann de Bono - Institute of Cancer ResearchJames Nagarajah - Radboud University NijmegenOliver Sartor - Mayo ClinicXiao X. Wei - Dana-Farber Cancer InstituteLuke T. Nordquist - XCancer, Omaha, NE, United StatesVadim S. Koshkin - University of California, San FranciscoKim N. Chi - University of British ColumbiaBernd J. Krause - University of RostockKen Herrmann - Essen University HospitalKambiz Rahbar - University Hospital MünsterAdrian Vickers - RTI Health SolutionsOsvaldo Mirante - Novartis (Switzerland)Ray Ghouse - Novartis (Switzerland)Karim Fizazi - Université Paris-SaclayScott T. Tagawa - Cornell University
- Publication Details
- Cancer, Vol.130(20), pp.3426-3435
- Number of pages
- 10
- Grant note
- Novartis (http://data.elsevier.com/vocabulary/SciValFunders/100004336) MR/W018217/1 / Medical Research Council (http://data.elsevier.com/vocabulary/SciValFunders/501100000265) Medical Research Council (http://data.elsevier.com/vocabulary/SciValFunders/501100000265)
- Identifiers
- 991006262542702656
- Academic Unit
- Radiology
- Language
- English
- Resource Type
- Journal article
Journal article
Correlation analyses of radiographic progression-free survival with clinical and health-related quality of life outcomes in metastatic castration-resistant prostate cancer: Analysis of the phase 3 VISION trial
Cancer, Vol.130(20), pp.3426-3435
10/15/2024
PMID: 39031642
Metrics
1 Record Views